Physician profile
Michael Burke
NPI 1043236557
$9,538.81
in general payments reported to CMS, 2019-2025
11 companies · $1,753 in 2025
The $1,753 reported for 2025 was more than what 85% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.90 · 2020: $53.00 · 2021: $61.57 · 2022: $4,415 · 2023: $3,000 · 2024: $189 · 2025: $1,753.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Food and Beverage: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Food and Beverage | $442.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,616.83 | 2022-2025 | Da Vinci Surgical System |
| Inspire Medical Systems, INC. | $422.14 | 2024-2025 | Inspire |
| Glaxosmithkline, LLC. | $143.89 | 2019-2022 | |
| Harmony Biosciences LLC | $123.03 | 2022 | |
| Merck Sharp & Dohme LLC | $88.80 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $54.94 | 2019-2021 | |
| Astellas Pharma US INC | $21.39 | 2020 | |
| Gilead Sciences, INC. | $21.12 | 2022 | |
| Olympus America INC. | $20.00 | 2025 | |
| Electromed, INC. | $13.94 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Burke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.